FDG positron emission tomography/computerized tomography features of bleomycin-induced pneumonitis

被引：9

作者：

Kirsch, Jacobo ^{[1
]}

Arrossi, Andrea V. ^{[1
]}

Yoon, John K. ^{[1
]}

Wu, Guiyun ^{[1
]}

Neuniann, Donald R. ^{[1
]}

机构：

[1] Cleveland Clin Fdn, Cleveland, OH 44195 USA

来源：

JOURNAL OF THORACIC IMAGING | 2006年 / 21卷 / 03期

关键词：

drug toxicity; lymphoma; positron emission tomography;

D O I：

10.1097/01.rti.0000209821.43379.8a

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Bleomycin is a widely used chemotherapeutic that has been shown to induce life-threatening interstitial lung disease in a small subset of patients. We report a case of bleomycin-induced pneumonitis in a patient treated for Hodgkin lymphoma with severe clinical respiratory symptoms, a marked restrictive pattern on pulmonary function tests, and FDG avid lymphadenopathy and diffuse increased uptake involving both lungs on imaging. To our knowledge, the in-line computed tomography/18F-fluorodeoxyglucose positron emission tomography of bleomycin induced pneumonitis has not been previously reported in the literature.

引用

页码：228 / 230

页数：3

共 8 条

[1] F-18 fluorodeoxyglucose chest uptake in lung inflammation and infection [J].